SmithKline Denavir $10 Mil. DTC Television, Print Campaign Debuts July 12
Executive Summary
SmithKline Beecham's Denavir (penciclovir) $10 mil. direct-to-consumer campaign will debut July 12.
You may also be interested in...
Denavir OTC Switch Falters On Viral Resistance Questions
Two FDA advisory committees unanimously disagreed on whether to recommend approval of the Rx-to-OTC switch of SmithKline Beecham's Denavir 1% penciclovir cream for cold sores on Dec. 1.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials